100% Tax offset partnership
improving
lives
Enabling millions suffering with Parkinson’s disease (PD) access to an FDA Breakthrough therapeutic device.
OPPORTUNITY
For the first time, FDA has granted Breakthrough Designation for a treatment that promises to significantly improve Parkinson’s beyond current medical care. Join with us in making this discovery a reality for the millions of people who suffer with Parkinson’s disease, as we work towards finding a cure.
INVESTOR INCENTIVE
Federal and State Tax Laws allow investors to receive a 100% tax offset for funding research such as getting new treatments through FDA approval. We are making great progress and should have FDA clearance in 2-3 years.
About Us
BeatPD has partnered with PhotoPharmics and is opening the door to improved health for people suffering with PD by funding the PhotoPharmics’ FDA Breakthough clinical trial. Clinical trial and related expenses can be credited against the investor’s income as an offset to their tax liabilities.* After the clinical trial, investors can become shareholders in PhotoPharmics through the buyout agreement and participate in potential long-term capital gains.*
PhotoPharmics is a pioneer in researching the underlying mechanisms that contribute to neurodegenerative diseases. They have world class teams with the expertise to bring these new treatments to market.
Let's Work Together!
*As with any tax and investment matter, it is important to consult with your tax and investment advisors
100% Tax offset partnership
improving
lives
Enabling millions suffering with Parkinson’s disease (PD) access to an FDA Breakthrough therapeutic device.
OPPORTUNITY
For the first time, FDA has granted Breakthrough Designation for a treatment that promises to significantly improve Parkinson’s beyond current medical care. Join with us in making this discovery a reality for the millions of people who suffer with Parkinson’s disease, as we work towards finding a cure.
INVESTOR INCENTIVE
Federal and State Tax Laws now allow investors to also receive a 100% tax offset for helping to fund work such as getting new treatments through FDA approval. We’re almost there and should have FDA approval within 3 years.
About Us
BeatPD has partnered with PhotoPharmics and is opening the door to improved health for people suffering with PD by funding the FDA Breakthough clinical trial. Clinical trial and related expenses can be credited against the investor’s income as an offset to their tax liabilities.* After the clinical trial, investors can become shareholders in PhotoPharmics through the buyout agreement and participate in potential long-term capital gains.*
PhotoPharmics is a pioneer in researching the underlying mechanisms that contribute to neurodegenerative diseases. They have world class teams with the expertise to bring these new treatments to market.
Let's Work Together!
*As with any tax and investment matter, it is important to consult with your tax and investment advisors
Address
947 South 500 East, Suite 110
American Fork, UT 84003 USA
Phone
801.770.6960
Address
947 South 500 East, Suite 110
American Fork, UT 84003 USA
Phone
801.770.6960
© 2023 beatPD, LLC. All Rights Reserved.